HPR56 Challenges of Funding Orphan Medicinal Products in Canada: Quantification of Approval Rate and Reimbursement
Abstract
Authors
M Santosuosso M Jessa-Jablonska M Ofir J O'Neill M Gibson M Hazel Y Gruenbaum Y Lipschitz G Gurfinkel